BN/CC isosterism in borazaronaphthalenes towards phosphodiesterase 10A (PDE10A) inhibitors

被引：58
|
作者：
Vlasceanu, Alexandru [3 ]
Jessing, Mikkel [1 ,2 ]
Kilburn, John Paul [1 ,2 ]
机构：
[1] H Lundbeck & Co AS, Discovery Chem, DK-2500 Valby, Denmark
[2] H Lundbeck & Co AS, DMPK, DK-2500 Valby, Denmark
[3] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2015年 / 23卷 / 15期
关键词：
Borazaronaphthalenes; PDE10A inhibitors; Antipsychotics; HETEROAROMATIC-COMPOUNDS; ENZYME-INHIBITORS; BORON COMPOUNDS; B-N; SCHIZOPHRENIA; 2,1-BORAZARONAPHTHALENES; SUBSTITUTION; DERIVATIVES; CHEMISTRY; DISCOVERY;
D O I：
10.1016/j.bmc.2015.06.019
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The application of BN/CC isosterism is explored as a method of expanding the scope of core scaffolds in biologically active compounds. The viability of potential drug candidates incorporating BN-heteroaromatic moieties was investigated through the synthesis of BN-substituted analogs to known phosphodiesterase (PDE10A) inhibitors, namely MP10 and a selection of N-methylanilide analogs. These in some cases revealed unexpectedly potent and relatively stable derivatives, providing further support for the potential of BN-incorporation in medicinal chemistry. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4453 / 4461
页数：9
相关论文
共 50 条
  • [31] Evaluation of Phosphodiesterase 10A (PDE10A) Using MNI-659 PET Imaging in Huntington's Disease
    Jennings, Danna
    Barret, Olivier
    Friedman, Joseph
    Russell, David
    Tamagnan, Gilles
    Alagille, David
    Seibyl, John
    Marek, Kenneth
    NEUROLOGY, 2013, 80
  • [32] Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease
    Leuti, Alessandro
    Laurenti, Daunia
    Giampa, Carmela
    Montagna, Elena
    Dato, Clemente
    Anzilotti, Serenella
    Melone, Mariarosa A. B.
    Bernardi, Giorgio
    Fusco, Francesca R.
    NEUROBIOLOGY OF DISEASE, 2013, 52 : 104 - 116
  • [33] Insight into the structural requirements of pyrimidine-based phosphodiesterase 10A (PDE10A) inhibitors by multiple validated 3D QSAR approaches
    Halder, A. K.
    Amin, S. A.
    Jha, T.
    Gayen, S.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2017, 28 (03) : 253 - 273
  • [34] Discovery of potent, selective, and metabolically stable 4-(pyridin-3-yl)cinnolines as novel phosphodiesterase 10A (PDE10A) inhibitors
    Hu, Essa
    Kunz, Roxanne K.
    Rumfelt, Shannon
    Chen, Ning
    Buerli, Roland
    Li, Chun
    Andrews, Kristin L.
    Zhang, Jiandong
    Chmait, Samer
    Kogan, Jeffrey
    Lindstrom, Michelle
    Hitchcock, Stephen A.
    Treanor, James
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (06) : 2262 - 2265
  • [35] Striatum- and testis-specific phosphodiesterase PDE10A - Isolation and characterization of a rat PDE10A
    Fujishige, K
    Kotera, J
    Omori, K
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (03): : 1118 - 1127
  • [36] Characterization of the phosphodiesterase 10A (PDE10A) PET tracer [11C]MK-8193 in monkey and rat
    Hostetler, Eric
    Joshi, Aniket
    Zeng Zhizhen
    Fan Hong
    Eng, Waisi
    Purcell, Mona
    Daneker, Lori
    Gantert, Liza
    Meng Jun
    O'Malley, Stacey
    Chen Tsing-Bau
    Williams, Mangay
    Riffel, Kerry
    Smith, Sean
    Flores, Broc
    Raheem, Izzat
    Cox, Chris
    Coleman, Paul
    Cook, Jacquelynn
    Evelhoch, Jeff
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S317 - S317
  • [37] Examining expression of phosphodiesterase 10A (PDE10A) in Huntington's disease using 18F-MNI-659 PET
    Jennings, D.
    Papapetropoulos, S.
    Rikki, W. N.
    Barret, O.
    Friedman, J. H.
    Russell, D.
    Tamagnan, G.
    Alagille, D.
    Seibyl, J.
    Marek, K.
    MOVEMENT DISORDERS, 2013, 28 : S63 - S63
  • [38] Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia
    Zagorska, Agnieszka
    Bucki, Adam
    Partyka, Anna
    Jastrzebska-Wiesek, Magdalena
    Siwek, Agata
    Gluch-Lutwin, Monika
    Mordyl, Barbara
    Jaromin, Anna
    Walczak, Maria
    Wesolowska, Anna
    Kolaczkowski, Marcin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 233
  • [39] Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis
    Shipe, William D.
    Sharik, Steven S.
    Barrow, James C.
    McGaughey, Georgia B.
    Theberge, Cory R.
    Uslaner, Jason M.
    Yan, Youwei
    Renger, John J.
    Smith, Sean M.
    Coleman, Paul J.
    Cox, Christopher D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (19) : 7888 - 7894
  • [40] N-Acylhydrazones as inhibitors of PDE10A
    Gage, Jennifer L.
    Onrust, Rene
    Johnston, Derek
    Osnowski, Andrew
    MacDonald, Wendy
    Mitchell, Lee
    Ueroegdi, Laszlo
    Rohde, Alex
    Harbol, Kevin
    Gragerov, Sasha
    Dorman, Gyoergy
    Wheeler, Tom
    Florio, Vince
    Cutshall, Neil S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (14) : 4155 - 4159
12345